Omega Healthcare Investors/$OHI
1D1W1MYTD1Y5YMAX
Capital at risk
About Omega Healthcare Investors
Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.
- Ticker
- $OHI
- Sector
- Real Estate
- Primary listing
- NYSE
- Employees
- 69
- Headquarters
- Hunt Valley, United States
- Website
- www.omegahealthcare.com
OHI Metrics
BasicAdvanced
$14B
16.80
$2.80
0.58
$2.69
5.77%
Price and volume
Market cap
$14B
Beta
0.58
52-week high
$52.39
52-week low
$39.26
Average daily volume
1.8M
Dividend rate
$2.69
Financial strength
Current ratio
1.323
Quick ratio
0.906
Long term debt to equity
0.589
Total debt to equity
0.713
Dividend payout ratio (TTM)
92.62%
Interest coverage (TTM)
3.94%
Profitability
EBITDA (TTM)
1,151.123
Gross margin (TTM)
97.92%
Net profit margin (TTM)
68.06%
Operating margin (TTM)
64.85%
Effective tax rate (TTM)
1.79%
Revenue per employee (TTM)
$18,280,000
Management effectiveness
Return on assets (TTM)
4.91%
Return on equity (TTM)
16.53%
Valuation
Price to earnings (TTM)
16.805
Price to revenue (TTM)
11.1
Price to book
2.62
Price to tangible book (TTM)
2.99
Price to free cash flow (TTM)
15.722
Free cash flow yield (TTM)
6.36%
Free cash flow per share (TTM)
2.998
Dividend yield (TTM)
5.71%
Forward dividend yield
5.77%
Growth
Revenue change (TTM)
13.16%
Earnings per share change (TTM)
73.68%
3-year revenue growth (CAGR)
13.94%
10-year revenue growth (CAGR)
3.97%
3-year earnings per share growth (CAGR)
39.79%
10-year earnings per share growth (CAGR)
5.70%
3-year dividend per share growth (CAGR)
0.12%
10-year dividend per share growth (CAGR)
1.53%
What the Analysts think about OHI
Analyst ratings (Buy, Hold, Sell) for Omega Healthcare Investors stock.
Analyst projections of the future price of Omega Healthcare Investors stock.
Bulls say / Bears say
Omega raised 2026 AFFO guidance to $3.22–$3.26 per share, lifting the midpoint to $3.24, reflecting confidence in its accretive investment and robust pipeline (TradingView News)
The board increased the quarterly dividend by $0.01 to $0.68 per share, payable August 14, 2026, underscoring strong cash flow coverage and shareholder returns (TradingView News)
Omega expanded its strategic partnership with Saber, completing $124.3 million of net investments and adding 27 facilities through its 49% Saber PropCo JV stake, bolstering operator diversification and portfolio growth (TradingView News)
Sequential AFFO and FAD were effectively flat in Q2 due to a $563 million headwind from asset sales, highlighting volatility in recurring cash flows (Investing.com)
Omega holds $139.8 million in term loans and $8.7 million of debtor-in-possession financing to bankrupt operator Genesis, creating repayment uncertainty pending the Chapter 11 outcome (Omega Press Release)
The announced retirements of 25-year CEO Taylor Pickett and CFO Robert Stephenson introduce leadership transition risk with potential impacts on strategic consistency (Motley Fool)
Data summarised monthly by Lightyear AI. Last updated on 5 Sept 2026.
OHI Financial Performance
Revenues and expenses
OHI Earnings Performance
Company profitability
Upcoming events
No upcoming events
OHI News
AllArticlesVideos
Funds containing OHI
AllUSDGBPEUR
Fund name | Fund size | $OHI weighting |
|---|---|---|
iShares Developed Markets Property Yield$IDWP | $1.2B | 0.83% |
iShares Developed Markets Property Yield£IWDP | £859M | 0.83% |
SPDR S&P 400 US Mid Cap$SPY4 | $6.3B | 0.40% |
SPDR S&P 400 US Mid Cap£SPX4 | £4.7B | 0.40% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.20% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.